Latest News

Date Title Topic
19 Aug 2013 Signatures of Mutational Processes in Cancer Translational research
31 Jul 2013 European Medicines Agency Recommends Granting a Marketing Authorisation for Filgrastim (Grastofil) Palliative and supportive care - Anticancer agents & Biologic therapy
30 Jul 2013 European Medicines Agency Recommends Changes to the Use of Metoclopramide Palliative and supportive care - Anticancer agents & Biologic therapy
29 Jul 2013 European Medicines Agency recommends granting a marketing authorisation for afatinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
25 Jul 2013 A New Paradigm Shift: Platinum-Based Doublets Better than Monotherapy even in Patients with Advanced Non-Small Cell Lung Cancer and Performance Status 2 Lung and other thoracic tumours
24 Jul 2013 WINTHER Trial Aims to Offer Improved Cancer Care Personalised medicine - Anticancer agents & Biologic therapy
Clinical Research Fellowship in Oncology Targeted Therapy in Melanoma, UK
23 Jul 2013 Paradoxical Oncogenic Transformation Melanoma - Anticancer agents & Biologic therapy
22 Jul 2013 Radium-223 in Metastatic Prostate Cancer Genitourinary cancers - Anticancer agents & Biologic therapy
19 Jul 2013 Aflibercept in Colorectal Cancer: Indication of Minor Added Benefit Gastrointestinal cancers - Anticancer agents & Biologic therapy
16 Jul 2013 FDA Approves Afatinib for the First Line Treatment of Patients with Metastatic NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
15 Jul 2013 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Panitumumab Gastrointestinal cancers - Anticancer agents & Biologic therapy
12 Jul 2013 ESMO Press Release: ESMO Announces President for the Years 2016-2017
ESMO Election 2016-2017